GU Oncology Now Editors

The editors of GU Oncology Now are part of an experienced team of medical writers and researchers who report the latest news and provide commentary in the genitourinary oncology space.

Articles by GU Oncology Now Editors

Articles from the December 2022 issue of the GU Oncology Now Journal
Read More
Articles from the November 2022 issue of the GU Oncology Now Journal
Articles from the October 2022 issue of the GU Oncology Now Journal
GU Oncology Now EditorsExpert Interviews | January 10, 2023
Cell-based therapies have shown efficacy in disease settings, but for solid tumors, research has proceeded at a slower pace.
Articles from the September 2022 issue of the GU Oncology Now Journal
GU Oncology Now EditorsRLT | November 15, 2022
Evan Ya-Wen Yu, MD, talks about different types of precision medicine, the future of precision medicine, and more.
GU Oncology Now EditorsRLT | December 1, 2022
Part two of an interview with Russell Szmulewitz, MD on the benefits of PSMA-PET for high-risk and advanced prostate cancer.
GU Oncology Now EditorsRLT | December 2, 2022
Part one of an interview with Russell Szmulewitz, MD on the benefits of PSMA-PET for high-risk and advanced prostate cancer.
GU Oncology Now EditorsRLT | November 15, 2022
Evan Ya-Wen Yu, MD, discusses what precision medicine is, how patients were treated before precision medicine, and more.
GU Oncology Now EditorsJournal | October 21, 2022
Prostate cancer highlights from ASCO 2022 are discussed, including the ENZAMET trial design and TheraP trial data.
Articles from the July 2022 issue of the GU Oncology Now Journal
Articles from the June 2022 issue of the GU Oncology Now Journal
GU Oncology Now EditorsRLT | November 15, 2022
Drs. Michael Morris and Akhil Saji discuss the future of PSMA-targeted therapies in advanced prostate cancer.
GU Oncology Now EditorsRenal Cell Carcinoma | September 13, 2022
RLRN has been widely used in the surgical treatment of renal cancer due to small wound, less bleeding, and rapid recovery.